# Reversing Ticagrelor's Effects With Fresh Platelets

> **NCT02201394** · PHASE4 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 20 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ticagrelor loading dose
- **DRUG:** Aspirin loading dose
- **DRUG:** Ticagrelor maintenance dose
- **DRUG:** Aspirin maintenance dose

## Key facts

- **NCT ID:** NCT02201394
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201394, "Reversing Ticagrelor's Effects With Fresh Platelets". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02201394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*